Published in Surgery on October 01, 2003
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
Intraabdominal septic complications following bowel resection for Crohn's disease: detrimental influence on long-term outcome. Int J Colorectal Dis (2008) 0.99
Does infliximab increase complications after surgery for inflammatory bowel disease? F1000 Med Rep (2009) 0.93
Anti-Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position Paper. Inflamm Bowel Dis (2015) 0.93
Preoperative optimization of Crohn's disease. Clin Colon Rectal Surg (2007) 0.81
Preoperative optimization of crohn disease. Clin Colon Rectal Surg (2013) 0.80
Body Mass Index Is a Marker of Nutrition Preparation Sufficiency Before Surgery for Crohn's Disease From the Perspective of Intra-Abdominal Septic Complications: A Retrospective Cohort Study. Medicine (Baltimore) (2015) 0.77
Post-operative abdominal complications in Crohn's disease in the biological era: Systematic review and meta-analysis. World J Gastrointest Surg (2016) 0.77
Perioperative Considerations in Crohn Disease and Ulcerative Colitis. Clin Colon Rectal Surg (2016) 0.75
Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study. United European Gastroenterol J (2015) 0.75
Risk factors and implications of anastomotic complications after surgery for Crohn's disease. World J Gastrointest Surg (2015) 0.75
Impact of preoperative steroid or immunosuppressant use on short-term outcomes following colectomy in Crohn's disease patients. Tech Coloproctol (2017) 0.75
Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. N Engl J Med (2010) 8.02
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol (2013) 7.81
Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol (2009) 6.10
Mortality rate of bullous pemphigoid in a US medical center. J Invest Dermatol (2004) 3.63
Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr (2003) 3.49
Animal models for medical countermeasures to radiation exposure. Radiat Res (2010) 2.83
Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem (2002) 2.67
Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr (2011) 2.49
Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol (2007) 2.20
Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis (2009) 2.03
Narcotic use in patients with Crohn's disease. Am J Gastroenterol (2005) 1.83
Ambient air pollution correlates with hospitalizations for inflammatory bowel disease: an ecologic analysis. Inflamm Bowel Dis (2010) 1.73
Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology (2008) 1.67
Simple score to identify colectomy risk in ulcerative colitis hospitalizations. Inflamm Bowel Dis (2010) 1.67
Comparative genomics of Ceriporiopsis subvermispora and Phanerochaete chrysosporium provide insight into selective ligninolysis. Proc Natl Acad Sci U S A (2012) 1.61
Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells. Am J Physiol Cell Physiol (2004) 1.61
Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol (2010) 1.58
Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis (2008) 1.57
A novel risk score to stratify severity of Crohn's disease hospitalizations. Am J Gastroenterol (2010) 1.56
QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States. Inflamm Bowel Dis (2011) 1.55
Acetazolamide reduces referred postoperative pain after laparoscopic surgery with carbon dioxide insufflation. Anesthesiology (2003) 1.52
Development of novel assays for lignin degradation: comparative analysis of bacterial and fungal lignin degraders. Mol Biosyst (2010) 1.51
Food dye use in enteral feedings: a review and a call for a moratorium. Nutr Clin Pract (2002) 1.45
Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume. Am J Gastroenterol (2008) 1.44
Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy. J Clin Gastroenterol (2003) 1.44
Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation. Gastroenterology (2003) 1.44
Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.41
Pain and inflammatory bowel disease. Inflamm Bowel Dis (2009) 1.39
Multidetector computerized tomography urography as the primary imaging modality for detecting urinary tract neoplasms in patients with asymptomatic hematuria. J Urol (2008) 1.37
Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol (2008) 1.36
Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol (2007) 1.29
The vascular contribution in the pathogenesis of inflammatory bowel disease. Am J Physiol Heart Circ Physiol (2003) 1.23
CXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrity. Am J Physiol Gastrointest Liver Physiol (2004) 1.21
Human intestinal microvascular endothelial cells express Toll-like receptor 5: a binding partner for bacterial flagellin. J Immunol (2004) 1.19
Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey. Inflamm Bowel Dis (2009) 1.19
Trends in ambulatory and emergency room visits for inflammatory bowel diseases in the United States: 1994-2005. Am J Gastroenterol (2009) 1.16
Clostridium difficile enteritis: an early postoperative complication in inflammatory bowel disease patients after colectomy. J Gastrointest Surg (2007) 1.15
Impact of Clostridium difficile on inflammatory bowel disease. Expert Rev Gastroenterol Hepatol (2010) 1.13
The intestinal microvasculature as a therapeutic target in inflammatory bowel disease. Ann N Y Acad Sci (2006) 1.12
Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci (2012) 1.10
Left ventricular ejection time on echocardiography predicts long-term mortality in light chain amyloidosis. J Am Soc Echocardiogr (2009) 1.10
Permanent work disability in Crohn's disease. Am J Gastroenterol (2007) 1.07
Volume and yield of screening colonoscopy at a tertiary medical center after change in medicare reimbursement. Am J Gastroenterol (2003) 1.05
Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling. Proc Natl Acad Sci U S A (2013) 1.03
Mucosal angiogenesis regulation by CXCR4 and its ligand CXCL12 expressed by human intestinal microvascular endothelial cells. Am J Physiol Gastrointest Liver Physiol (2004) 1.03
Mechanisms of endotoxin tolerance in human intestinal microvascular endothelial cells. J Immunol (2003) 1.03
Effect of curcumin on acidic pH-induced expression of IL-6 and IL-8 in human esophageal epithelial cells (HET-1A): role of PKC, MAPKs, and NF-kappaB. Am J Physiol Gastrointest Liver Physiol (2008) 1.02
Clostridium difficile and inflammatory bowel disease. Gastroenterol Clin North Am (2009) 1.02
Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling. Cell Commun Signal (2004) 1.02
A nationwide analysis of changes in severity and outcomes of inflammatory bowel disease hospitalizations. J Gastrointest Surg (2010) 1.00
Clostridium difficile and inflammatory bowel disease. Med Clin North Am (2010) 0.99
Human esophageal microvascular endothelial cells respond to acidic pH stress by PI3K/AKT and p38 MAPK-regulated induction of Hsp70 and Hsp27. Am J Physiol Cell Physiol (2006) 0.99
Mucosal IgG4 cell infiltration in ulcerative colitis is linked to disease activity and primary sclerosing cholangitis. Inflamm Bowel Dis (2013) 0.97
Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort. J Clin Gastroenterol (2016) 0.96
Case report: magnetic resonance imaging in the diagnosis of epidural abscess complicating perirectal fistulizing Crohn's disease. Inflamm Bowel Dis (2003) 0.96
The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology. Inflamm Bowel Dis (2005) 0.96
Chronic sinonasal disease in patients with inflammatory bowel disease. Am J Rhinol (2003) 0.95
Transrectal and transvaginal sonographic intervention of infected pelvic fluid collections: a complete approach. Ultrasound Q (2005) 0.93
Role of hydrogen peroxide in ACh-induced dilation of human submucosal intestinal microvessels. Am J Physiol Heart Circ Physiol (2004) 0.92
Cyclosporine A enhances leukocyte binding by human intestinal microvascular endothelial cells through inhibition of p38 MAPK and iNOS. Paradoxical proinflammatory effect on the microvascular endothelium. J Biol Chem (2002) 0.91
Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease. J Clin Gastroenterol (2007) 0.91
Vascular cell adhesion molecule-1 expression in human intestinal microvascular endothelial cells is regulated by PI 3-kinase/Akt/MAPK/NF-kappaB: inhibitory role of curcumin. Am J Physiol Gastrointest Liver Physiol (2009) 0.91
The high prevalence of restless legs syndrome symptoms in liver disease in an academic-based hepatology practice. J Clin Sleep Med (2008) 0.90
Butyrate modulates gene and protein expression in human intestinal endothelial cells. Biochem Biophys Res Commun (2003) 0.90
New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease. Inflamm Bowel Dis (2010) 0.89
Longitudinal quality of life assessment of patients with hepatocellular carcinoma after primary transarterial chemoembolization. J Vasc Interv Radiol (2010) 0.89
The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey. Dig Dis Sci (2009) 0.89
Physician density and hospitalization for inflammatory bowel disease. Inflamm Bowel Dis (2011) 0.89
Infliximab retreatment in adults and children with Crohn's disease: risk factors for the development of delayed severe systemic reaction. Am J Gastroenterol (2002) 0.89
History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis. Inflamm Bowel Dis (2009) 0.88
Mesenteric venous thrombosis in inflammatory bowel disease. J Clin Gastroenterol (2005) 0.88
Radiation induces endothelial dysfunction in murine intestinal arterioles via enhanced production of reactive oxygen species. Arterioscler Thromb Vasc Biol (2005) 0.88
Successful treatment of an acute flare of steroid-resistant Crohn's colitis during pregnancy with unfractionated heparin. Inflamm Bowel Dis (2002) 0.87
Does breast tumor location influence success of sentinel lymph node biopsy? J Am Coll Surg (2002) 0.87
Treatment of ulcerative colitis in the elderly. Dig Dis (2009) 0.86
The inflammatory bowel disease live interinstitutional and interdisciplinary videoconference education (IBD LIVE) series. Inflamm Bowel Dis (2014) 0.86
Isolation and characterization of human esophageal microvascular endothelial cells: mechanisms of inflammatory activation. Am J Physiol Gastrointest Liver Physiol (2003) 0.86
Radiographic underestimation of small bowel stricturing Crohn's disease: a comparison with surgical findings. Surgery (2004) 0.86
Expression of vascular cell adhesion molecule-1 (CD 106) in normal and neoplastic human esophageal squamous epithelium. Int J Oncol (2006) 0.86
Novel mechanism of vasodilation in inflammatory bowel disease. Arterioscler Thromb Vasc Biol (2005) 0.86
Sodium butyrate inhibits angiogenesis of human intestinal microvascular endothelial cells through COX-2 inhibition. FEBS Lett (2003) 0.85
Clinical factors contributing to rapid reoperation for Crohn's disease patients undergoing resection and/or strictureplasty. J Gastrointest Surg (2007) 0.85